| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8535550 | Life Sciences | 2018 | 6 Pages |
Abstract
Acamprosate may be a useful therapy for FXS and potentially other autism spectrum disorders. However, understanding the molecular mechanisms involved with different doses of this drug will likely be necessary to obtain optimal results.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Russell L. Hutson, Rachel L. Thompson, Andrew P. Bantel, Charles R. Tessier,